Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Gaviscon
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gaviscon Advance oral susp peppermint (Reckitt Benckiser)
0101021B0BEBEAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 177,286 |
|
Gaviscon Advance oral suspension aniseed (Reckitt Benckiser)
0101021B0BEAIAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 126,592 |
|
Gaviscon Infant oral powder sachets
0101021B0BEADAJ
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 66,395 |
|
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser)
0101021B0BEAQAP
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 43,633 |
|
Gaviscon Original Aniseed Relief
0101021B0BEACAH
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 16,535 |
|
Gaviscon Peppermint Liquid Relief
0101021B0BEAFAH
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 13,415 |
|
Gaviscon Double Action chewable tablets mint
0101021B0BEARA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 10,201 |
|
Gaviscon Double Action Liquid peppermint
0101021B0BEASA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 8,403 |
|
Gaviscon Peppermint chewable tablets
0101021B0BEAUAR
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 3,268 |
|
Gaviscon Double Action Liquid aniseed
0101021B0BEAVA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 3,182 |
|
Gaviscon Double Action chewable tablets mixed berries
0101021B0BEBFA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 666 |
|
Gaviscon Double Action Liquid 10ml sachets
0101021B0BEBDA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 547 |
|
Gaviscon Strawberry chewable tablets
0101021B0BEAWAR
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 216 |
|
Gaviscon Liquid 10ml sachets
0101021B0BEAJAM
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 195 |
|
Gaviscon Cool Liquid
0101021B0BEANAH
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 16 |
|
Gaviscon Double Action Liquid mixed berries
0101021B0BEBGA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 10 |
|
Gaviscon 500mg chewable tablets peppermint
0101021B0BEABAG
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 5 |
|
Gaviscon Advance Mint chewable tablets (Forum Health)
0101021B0BEAYAP
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 3 |
|
Gaviscon Advance oral suspension aniseed (Forum Health)
0101021B0BEBAAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 2 |
|
Gaviscon Cool chewable tablets
0101021B0BEAPAR
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 2 |
|
Gaviscon Advance oral suspension peppermint (Forum Health)
0101021B0BEBCAL
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 1 |
|
Gaviscon Extra Strength chewable tablets peppermint
0101021B0BEAMAG
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 1 |
|
Gaviscon 500mg chewable tablets lemon
0101021B0BEAHAG
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gaviscon Extra Strength chewable tablets lemon
0101021B0BEALAG
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gaviscon Instants Tropical Fruit Flavour oral powder sachets
0101021B0BEAXA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.